Compare Graham Holdings Company Common Stock (GHC) vs Liquidia Corporation Common Stock (LQDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Graham Holdings Company Common Stock vs Liquidia Corporation Common Stock — how do they compare? Graham Holdings Company Common Stock trades at $1,190.11 (market cap $4.97B), while Liquidia Corporation Common Stock trades at $33.66 (market cap $2.40B). The key difference: Graham Holdings Company Common Stock is far larger — about 2.1× Liquidia Corporation Common Stock's market cap, and Graham Holdings Company Common Stock pays a 0.64% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Graham Holdings Company Common Stock for 0 Days and Liquidia Corporation Common Stock for 0 Days on average.
| GHC | LQDA | |
|---|---|---|
Market Cap | $4.97B | $2.40B |
Volume | 27,383 | 2,857,547 |
Sector | Industrials | Health |
52-Week High | $1.23K | $91.03 |
52-Week Low | $949.84 | $22.02 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.06B | $2.30B |
Dividend Yield | 0.64% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Graham Holdings Company Common Stock
Graham Holdings Company is a diversified holding company with operations spanning education services (Kaplan), television broadcasting (Graham Media Group), healthcare services, and manufacturing, among other businesses; it was formerly known as The Washington Post Company.
Read more on GHC →About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →
